Cephavet: Uses, dosage, side effects, warnings & patient reviews

What is Cephavet?

Cephavet is a veterinary prescription medication containing cephalexin, a first-generation cephalosporin antibiotic. Cephalexin has bactericidal activity against many susceptible Gram-positive bacteria and some Gram-negative organisms. It works by binding to penicillin-binding proteins and interfering with bacterial cell wall synthesis, which leads to bacterial cell death.

In veterinary medicine, cephalexin is used mainly for bacterial skin and soft-tissue infections in dogs and cats, especially infections involving susceptible staphylococci. It is also used in selected cases of urinary, respiratory, ear, or bone infection when a veterinarian determines that cephalexin is an appropriate choice.

Cephavet is available in oral tablet and oral suspension formulations. It is intended for animal use only. On a human-health website such as iMedix, any mention of cephalexin as a class-related antibiotic is provided only for educational context and not because veterinary and human products are interchangeable. For broader class context, see the category of antibiotic medications.

How to Administer Cephavet

Cephavet is administered orally. The prescribed dose, frequency, and duration are determined by a veterinarian based on the infection being treated, body weight, and the patient’s overall health.

General Administration

Tablets may be given directly by mouth or hidden in a small amount of food. The oral suspension should be shaken well before each use, and the dose should be measured with a calibrated dosing device. The full course should be completed exactly as prescribed, even if the pet appears better before treatment is finished.

Timing with Food

Cephavet may be administered with or without food. If vomiting or stomach upset occurs, giving the medication with a small amount of food may improve tolerance.

Missed Dose

If a dose is missed, administer it as soon as remembered unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not administer a double dose to compensate for the missed dose.

Duration of Treatment

Treatment duration depends on the infection site, severity, response to therapy, and whether follow-up reassessment is needed. Skin infections often require longer treatment than uncomplicated soft-tissue infections, and therapy should not be stopped early unless the veterinarian instructs otherwise.

Side Effects of Cephavet in Dogs and Cats

Adverse reactions associated with cephalexin are usually mild to moderate, with gastrointestinal upset reported most often. Dogs and cats should be monitored for vomiting, diarrhea, appetite changes, and any signs of allergic reaction.

Gastrointestinal disturbances remain the most commonly reported adverse events associated with cephalexin administration in dogs and cats.

What is Cephavet Used For in Veterinary Medicine?

Cephavet (cephalexin) is used for bacterial infections caused by susceptible organisms. The exact indication depends on the species, infection site, culture results when available, and veterinary judgment.

FDA-Approved Canine Indication (Cephalexin as a Veterinary Drug)

In the United States, cephalexin is FDA-approved in dogs for the treatment of secondary superficial bacterial pyoderma caused by susceptible strains of Staphylococcus pseudintermedius.

Additional Veterinary Uses (Often Extralabel)

In clinical veterinary practice, cephalexin is also used for selected infections outside the labeled canine superficial pyoderma indication, depending on the case and local susceptibility patterns. These may include:

• Skin and soft-tissue infections: deep pyoderma, wound infections, cellulitis, abscesses
• Urinary tract infections: selected cases caused by susceptible organisms
• Respiratory tract infections: selected bacterial upper or lower respiratory infections
• Ear infections: some bacterial otic infections as part of an appropriate treatment plan
• Bone infections: osteomyelitis in selected cases

Limitations of Use

Cephavet is not reliable for all bacterial pathogens. It should not be assumed effective against methicillin-resistant staphylococci, Pseudomonas aeruginosa, or enterococci. Use in animals with known beta-lactam allergy requires special caution.

Important Safety Concerns and Considerations

Beta-Lactam Cross-Reactivity

Animals with a history of hypersensitivity to penicillins may also react to cephalosporins such as cephalexin. Cephavet should therefore be used cautiously, or avoided, in patients with a known history of severe beta-lactam allergy.

Gastrointestinal Microbiome Disruption

As a broad-spectrum antibiotic, cephalexin can disrupt normal intestinal flora. This may contribute to antibiotic-associated diarrhea and overgrowth of non-susceptible organisms during or after therapy.

Development of Antibiotic Resistance

Incomplete courses and use for inappropriate indications increase the risk of bacterial resistance. This is particularly relevant in pyoderma, where treatment often requires weeks rather than days.

Use in Cats: Specific Considerations

Cats may be more prone to bitter-taste reactions such as foaming or hypersalivation after oral dosing. They can also be difficult to medicate safely, so oral formulations should be administered carefully and exactly as directed.

Regulatory Status

Brand availability and authorization may vary by country. This page focuses on cephalexin as a veterinary active ingredient and does not imply that any specific market-specific brand is authorized in every jurisdiction.

Critical Warnings for Cephavet Use

For Veterinary Use Only

Cephavet is formulated for use in animals and should be used only under veterinary direction. Keep this medication in a secure location out of the reach of children.

Hypersensitivity Reactions

Discontinue administration and seek veterinary care immediately if signs of an allergic reaction develop, including:

• Facial swelling
• Urticaria (hives)
• Respiratory distress or wheezing
• Sudden vomiting or diarrhea with collapse

Severe Gastrointestinal Disease

If severe, persistent, or bloody diarrhea occurs during or after treatment, discontinue Cephavet and consult a veterinarian promptly. Severe antibiotic-associated enteric disease may require specific management.

Renal Impairment

Because cephalexin is excreted mainly by the kidneys, patients with renal disease may accumulate the drug and require dose adjustment or longer dosing intervals.

Cross-Reactivity with Penicillins

Use with caution in animals known to be hypersensitive to penicillins or other beta-lactam antibiotics.

Not for Viral Infections

Cephavet is ineffective against viral diseases. Use for non-bacterial conditions exposes the animal to unnecessary risk and contributes to antimicrobial resistance.

Cephavet Dosage Information

The following dosage recommendations are based on veterinary prescribing references and accepted clinical practice. A veterinarian must determine the appropriate dose based on the patient’s weight, infection type, and renal function.

Dosage Adjustments

• Renal impairment: Reduce dose or extend dosing interval when clinically indicated.
• Hepatic impairment: Routine liver-based dose reduction is not usually the primary issue, but overall clinical status still matters.
• Elderly patients: Consider renal function before and during prolonged therapy.

Overdose Information

Signs of acute overdose may include severe vomiting, diarrhea, lethargy, and marked gastrointestinal intolerance. In cases of suspected overdose, discontinue the medication and contact a veterinarian or animal poison control center immediately.

Drug Interactions with Cephavet

The following drug interactions are identified or clinically relevant for cephalexin. A complete medication history, including prescription and over-the-counter products, should be reviewed before therapy starts.

Additional Information

Storage and Handling

Store Cephavet tablets at room temperature, protected from excessive light and moisture. Oral suspension products should be stored exactly according to the manufacturer’s instructions, including any reconstitution, refrigeration, or discard-after-opening guidance specific to the product supplied.

Regulatory Status and Availability

Cephavet is a market-specific veterinary brand. Availability, authorization, and dispensing rules may vary by country. This page focuses on cephalexin as a veterinary active ingredient and should not be read as confirmation of legal availability in every jurisdiction.

Reporting Adverse Events

Adverse events associated with Cephavet or other cephalexin products should be reported to the manufacturer and to the relevant veterinary medicines authority when applicable. Reporting helps improve post-market safety monitoring.

Key Pharmacological Properties

• Absorption: Cephalexin is absorbed rapidly after oral administration.
• Peak concentration: Peak serum levels are typically reached within a few hours.
• Elimination: The drug is excreted primarily unchanged in urine.
• Renal dependence: Impaired kidney function can increase exposure and may require dosing adjustment.

References and Medical Sources

The information on this page is compiled from peer-reviewed veterinary literature, FDA-approved veterinary labeling, and authoritative veterinary pharmacology references.

1. eCFR. 21 CFR § 520.376 — Cephalexin. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-E/part-520/section-520.376
2. DailyMed. RILEXINE (cephalexin) chewable tablets for dogs. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84506621-8429-4b65-a7b4-1c9375dcbd89
3. Weese JS, Blondeau JM, Boothe D, et al. International Society for Companion Animal Infectious Diseases (ISCAID) guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats. Vet J. 2019;247:8-25. DOI: 10.1016/j.tvjl.2019.02.008
4. Loeffler A, Cain C, Ferrer L, et al. Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Vet Dermatol. 2025;36(3):234-282. DOI: 10.1111/vde.13342
5. Toma S, Cornegliani L, Persico P, Noli C. Efficacy and tolerability of once-daily cephalexin in canine superficial pyoderma: an open controlled study. J Small Anim Pract. 2008;49(8):384-391. DOI: 10.1111/j.1748-5827.2008.00585.x
6. Mason IS. Cephalosporins: pharmacological basis of clinical use in veterinary dermatology. Vet Dermatol. 1999;10(3):187-192. DOI: 10.1046/j.1365-3164.1999.00183.x
7. Veterinary Medicines Directorate (VMD). Summary of Product Characteristics for veterinary cephalexin oral suspension products. https://www.vmd.defra.gov.uk/productinformationdatabase/files/SPC_Documents/SPC_2048181.PDF

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.